Neutrophil-to-Lymphocyte Ratio in Predicting Outcomes of Patients With Aneurysmal Subarachnoid Hemorrhage in a Tertiary Care Hospital in Nepal

Sujan Paudel1 site in 1 country51 target enrollmentJune 10, 2022

ConditionsSAH (Subarachnoid Hemorrhage)

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: SAH (Subarachnoid Hemorrhage)
Sponsor: Sujan Paudel
Enrollment: 51
Locations: 1
Primary Endpoint: mRS score
Status: Completed
Last Updated: last year

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

This study uses Neutrophil-to-Lymphocyte Ratio to Predict Outcomes of Patients with Aneurysmal Subarachnoid Hemorrhage which will be beneficial in taking early decisions for surgery , patient counselling etc

Registry

clinicaltrials.gov

Start Date

June 10, 2022

End Date

July 13, 2023

Last Updated

last year

Study Type

Observational

Sex

All

Investigators

Sponsor

Sujan Paudel

Responsible Party

Sponsor Investigator

Principal Investigator

Sujan Paudel

Maharajgunj Medical Campus

Eligibility Criteria

Inclusion Criteria

•Patients \> 18 years of age, of either genders, ethnicity and location who presented to the emergency department within 72 hours of the onset of symptoms who underwent surgical or interventional treatment for SAH caused by a ruptured intracranial aneurysm

Exclusion Criteria

•excluded patients with traumatic SAH, history of infection or stroke within eight weeks, underlying cancer, severe kidney or liver disease, history of auto-immune or hematologic disorder lost to follow-up within three months and individuals declining informed consent.